Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

OCGN

OCGN News

Newswire

07:10

Ocugen's CEO to Present at NobleCon21 Emerging Growth Equity Conference.

07:03

Ocugen CEO to Present at NobleCon21, Highlighting Gene Therapy Progress

16:25

Ocugen Aims for Three BLA Filings in Next Three Years Amid Gene Therapy Expansion

06:41

Ocugen Q3 Revenue Surpasses Expectations, Gene and Cell Therapies Drive Growth

06:36

Ocugen's Q3 revenue up 43%, OCU410ST trial progresses, $20mln raised.

View More

About OCGN

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More